Peter Aronstam is Chief Financial Officer of Statera Biopharma, Inc.. Currently has a direct ownership of 141,370 shares of STAB, which is worth approximately $0. The most recent transaction as insider was on Jul 27, 2021, when has been sold 141,370 shares (Common Stock, par value $0.005 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 141K
0% 3M change
0% 12M change
Total Value Held $0

PETER ARONSTAM Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 27 2021
BUY
Grant, award, or other acquisition
-
141,370 Added 50.0%
141,370 Common Stock, par valu...
PA

Peter Aronstam

Chief Financial Officer
Fort Collins, CO

Track Institutional and Insider Activities on STAB

Follow Statera Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STAB shares.

Notify only if
Any

Insider Trading

Get notified when an Statera Biopharma, Inc. insider buys or sells STAB shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Statera Biopharma, Inc.

Track Activities on STAB